Dr. Prenika Jaglal

Prenika Jaglal is a South African researcher in clinical microbiology and infectious diseases, with a strong focus on antimicrobial resistance in neonatal and paediatric settings. Her work spans laboratory diagnostics, molecular epidemiology, and infection prevention, frequently linked to major tertiary hospitals and surveillance initiatives in South Africa. She contributes to research addressing high-burden infections in resource-constrained environments.

Her recent studies centre on multidrug-resistant Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries, integrating whole-genome sequencing and susceptibility testing to inform novel antibiotic combinations. She has also examined Candida auris outbreaks, paediatric burns unit antibiograms, and quality improvement interventions to strengthen infection prevention and antimicrobial stewardship.

Earlier contributions include work on drug-resistant tuberculosis diagnostics and the molecular epidemiology of MRSA. Across her publications, a consistent strength lies in translating microbiological surveillance data into practical clinical and public health strategies, supporting improved empiric therapy, outbreak response, and evidence-based policy in high-resistance settings.